Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer

被引：0
|
作者：
Michele Moschetta
Gabriel Mak
Joana Hauser
Catriona Davies
Mario Uccello
Hendrik-Tobias Arkenau
机构：
[1] Sarah Cannon Research Institute,Drug Development Unit
[2] University College London,undefined
来源：
Experimental Hematology & Oncology | / 6卷
关键词：
Dabrafenib; Trametinib; BRAF V600E mutation; Microsatellite instability; Endometrial cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer
    Moschetta, Michele
    Mak, Gabriel
    Hauser, Joana
    Davies, Catriona
    Uccello, Mario
    Arkenau, Hendrik-Tobias
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 5
  • [2] Granulomatous nephritis and dermatitis in a patient with BRAF V600E mutant metastatic melanoma treated with dabrafenib and trametinib
    Jansen, Yanina J.
    Janssens, Peter
    Hoorens, Anne
    Schreuer, Max S.
    Seremet, Teofila
    Wilgenhof, Sofie
    Neyns, Bart
    [J]. MELANOMA RESEARCH, 2015, 25 (06) : 550 - 554
  • [3] Targeted treatment (TT) after immune checkpoint inhibitors (ICIs) in BRAF V600E mutated (BRAFm) and deficient mismatch repair or microsatellite instability high (dMMR/MSI-H) metastatic colorectal cancer (mCRC)
    Ambrosini, M.
    Tougeron, D.
    Modest, P.
    Guimbaud, R.
    Kopetz, S.
    Decraecker, M.
    Sclafani, F.
    Coutzac, C.
    Lievre, A.
    Alouani, E. L.
    Marmorino, F.
    Pernot, S.
    Sinicrope, A.
    Elez Fernandez, E.
    Germani, M. M.
    Pietrantonio, F.
    Lonardi, S.
    Parent, P.
    Gallois, C.
    Taieb, J.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S32 - S32
  • [4] Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations
    Abraham, Jame
    [J]. JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (07): : 234 - 235
  • [5] Bayesian individual exposure estimation of dabrafenib alone or in combination with trametinib in mutated-BRAF V600E metastatic melanoma patients
    Goldwirt, Lauriane
    Pressiat, Claire
    Chami, Ichrak
    Jullien, Vincent
    Sauvageon, Helene
    Madelaine, Isabelle
    Lebbe, Celeste
    Mourah, Samia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
    Marks, Asher M.
    Bindra, Ranjit S.
    DiLuna, Michael L.
    Huttner, Anita
    Jairam, Vikram
    Kahle, Kristopher T.
    Kieran, Mark W.
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 (05)
  • [7] Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient
    Maurício Fernando Silva Almeida Ribeiro
    Franciele Hinterholz Knebel
    Fabiana Bettoni
    Rodrigo Saddi
    Karina Perez Sacardo
    Felipe Sales Nogueira Amorim Canedo
    João Victor Machado Alessi
    Andrea Kazumi Shimada
    José Flávio Gomes Marin
    Anamaria Aranha Camargo
    Artur Katz
    [J]. npj Precision Oncology, 5
  • [8] Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation
    Seo, Takuji
    Noguchi, Emi
    Yoshida, Masayuki
    Mori, Taisuke
    Tanioka, Maki
    Sudo, Kazuki
    Shimomura, Akihiko
    Yonemori, Kan
    Fujiwara, Yasuhiro
    Tamura, Kenji
    [J]. CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020, 2020
  • [9] Granulomatosis with polyangiitis in a patient treated with dabrafenib and trametinib for BRAF V600E positive lung adenocarcinoma
    Dimou, Anastasios
    Barron, Gregory
    Merrick, Daniel T.
    Kolfenbach, Jason
    Doebele, Robert C.
    [J]. BMC CANCER, 2020, 20 (01)
  • [10] Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient
    Silva Almeida Ribeiro, Mauricio Fernando
    Knebel, Franciele Hinterholz
    Bettoni, Fabiana
    Saddi, Rodrigo
    Sacardo, Karina Perez
    Nogueira Amorim Canedo, Felipe Sales
    Machado Alessi, Joao Victor
    Shimada, Andrea Kazumi
    Gomes Marin, Jose Flavio
    Camargo, Anamaria Aranha
    Katz, Artur
    [J]. NPJ PRECISION ONCOLOGY, 2021, 5 (01)
12345